Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6879 (MIR6879) is a predicted human microRNA gene encoding a short, non-coding RNA molecule that participates in the post-transcriptional regulation of gene expression. Like other microRNAs, MIR6879 is transcribed as part of a primary transcript, processed by Drosha and Dicer, and loaded into the RNA-induced silencing complex (RISC), where it guides the complex to imperfectly complementary mRNA targets. This interaction results in translational inhibition or degradation of the target mRNAs, influencing diverse cellular processes. No specific biological functions, disease associations, or drug interactions have been documented for MIR6879; this suggests either limited current functional annotation or uncertain biological relevance. Its predicted nature and lack of literature suggest it is not established as a therapeutic target and may have been included in genome annotations based on sequence prediction rather than validated function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6879 (MIR6879).